Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000315066-01-000525
Filing Date
2001-02-14
Accepted
2001-02-14 00:00:00
Documents
1

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G - 02-14-01 - MEDIMMUNE INCORPORATED 0001.txt SC 13G/A 12472
  Complete submission text file 0000315066-01-000525.txt   14446
Mailing Address 82 DEVONSHIRE STREET BOSTON MA 02109
Business Address 82 DEVONSHIRE ST BOSTON MA 02109 6175706339
FMR CORP (Filed by) CIK: 0000315066 (see all company filings)

EIN.: 161144965 | State of Incorp.: MA | Fiscal Year End: 1231
SIC: 0000

Mailing Address 35 W WATKINS MILL ROAD GAITHERSBURG MD 20878
Business Address 35 W WATKINS MILL RD GAITHERSBURG MD 20878 3014170770
MEDIMMUNE INC /DE (Subject) CIK: 0000873591 (see all company filings)

EIN.: 521555759 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-42057 | Film No.: 1539524
SIC: 2836 Biological Products, (No Diagnostic Substances)